event,time
58 years old ,0
    male ,0
    admitted to the hospital ,0
    lower abdominal pain ,-336
    loss of appetite ,-336
    aortic dissection (DeBakey IIIb) ,-70080
    body temperature 37.3°C ,0
    left abdominal tenderness ,0
    no swollen superficial lymph nodes ,0
    no leg edema ,0
    mild thrombocytopenia ,0
    hypoalbuminemia ,0
    elevated C-reactive protein (CRP) ,0
    elevated alkaline phosphatase ,0
    elevated γ-glutamyl transferase ,0
    elevated creatinine ,0
    elevated fibrinogen ,0
    elevated D-dimer ,0
    elevated serum soluble interleukin-2 receptor level ,0
    elevated rheumatoid factor ,0
    antinuclear antibody index 640 (speckled type) ,0
    anti-Sjögren’s-syndrome-related antigen A antibody index 240 ,0
    anti-Sjögren’s-syndrome-related antigen B antibody negative ,0
    anti-platelet antibody negative ,0
    serum levels of β-D-glucan normal (<6.0 pg/mL) ,0
    blood cultures negative ,0
    mild proteinuria ,0
    no hematuria ,0
    small pleural effusion ,0
    no other abnormal findings on computed tomography ,0
    platelet count decreased gradually ,24
    ascites increased ,24
    pleural effusion increased ,24
    renal insufficiency progression ,24
    bone marrow biopsy ,240
    severely hypocellular marrow ,240
    18-F-fluorodeoxyglucose uptake by left cervical and submandibular lymph nodes ,264
    cervical lymph node biopsy ,384
    prophylactic platelet transfusion ,384
    pulse therapy with methylprednisolone (1000 mg daily for 3 days) ,384
    lymph node size normal (8×5 mm) ,384
    germinal centers preserved but atrophic ,384
    high endothelial venules surrounded by plasma cell infiltration ,384
    serum interleukin-6 level 72.7 pg/mL (<4.0 pg/mL) ,384
    human herpes virus-8 not found ,384
    thrombocytopenia persisted ,384
    massive ascites persisted ,384
    multiple blood and platelet transfusions ,384
    tocilizumab (8 mg/kg body weight) initiated ,504
    prednisolone 1 mg/kg/day initiated ,504
    anasarca worsened ,504
    renal function worsened ,504
    transferred to intensive care unit ,504
    ventilator support ,504
    continuous hemofiltration ,504
    deteriorating hemodynamic status ,504
    five consecutive blood cultures sterile ,504
    restarted pulse therapy ,600
    intravenous immunoglobulin initiated ,648
    tocilizumab (8 mg/kg body weight) restarted ,696
    thrombocytopenia deteriorated ,696
    massive ascites deteriorated ,696
    gastrointestinal bleeding ,696
    methicillin-resistant Staphylococcus aureus sepsis ,696
    meropenem administered ,696
    teicoplanin administered ,696
    bacterial peritonitis ,888
    Stenotrophomonas maltophilia in ascitic fluid ,888
    antibiotics changed to daptomycin ,888
    tazobactam/piperacillin added ,888
    ciprofloxacin added later ,888
    gastrointestinal perforation ,1104
    candidemia (Candida glabrata and Candida lusitaniae) ,1224
    β-D-glucan elevated to 193.3 pg/mL ,1224
    micafungin administered ,1224
    trimethoprim-sulfamethoxazole administered ,1224
    death ,1368
    disseminated candidiasis ,1368
    secondary hemophagocytic lymphohistiocytosis ,1368
    hemophagocytosis in bone marrow ,1368
    ischemic and necrotic small and large intestines ,1368
    no macroscopic perforation ,1368
    lymph nodes normal size postmortem ,1368
    no TAFRO syndrome findings postmortem ,1368
